1. Home
  2. VSTM vs BLFY Comparison

VSTM vs BLFY Comparison

Compare VSTM & BLFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • BLFY
  • Stock Information
  • Founded
  • VSTM 2010
  • BLFY 1939
  • Country
  • VSTM United States
  • BLFY United States
  • Employees
  • VSTM N/A
  • BLFY N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • BLFY Commercial Banks
  • Sector
  • VSTM Health Care
  • BLFY Finance
  • Exchange
  • VSTM Nasdaq
  • BLFY Nasdaq
  • Market Cap
  • VSTM 239.9M
  • BLFY 226.4M
  • IPO Year
  • VSTM 2012
  • BLFY N/A
  • Fundamental
  • Price
  • VSTM $4.22
  • BLFY $10.01
  • Analyst Decision
  • VSTM Strong Buy
  • BLFY Hold
  • Analyst Count
  • VSTM 8
  • BLFY 2
  • Target Price
  • VSTM $12.00
  • BLFY $11.50
  • AVG Volume (30 Days)
  • VSTM 1.1M
  • BLFY 52.0K
  • Earning Date
  • VSTM 11-06-2024
  • BLFY 01-22-2025
  • Dividend Yield
  • VSTM N/A
  • BLFY N/A
  • EPS Growth
  • VSTM N/A
  • BLFY N/A
  • EPS
  • VSTM N/A
  • BLFY N/A
  • Revenue
  • VSTM $10,000,000.00
  • BLFY $40,112,000.00
  • Revenue This Year
  • VSTM N/A
  • BLFY N/A
  • Revenue Next Year
  • VSTM $53.90
  • BLFY $16.19
  • P/E Ratio
  • VSTM N/A
  • BLFY N/A
  • Revenue Growth
  • VSTM N/A
  • BLFY N/A
  • 52 Week Low
  • VSTM $2.10
  • BLFY $7.90
  • 52 Week High
  • VSTM $14.22
  • BLFY $11.48
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 47.50
  • BLFY 29.02
  • Support Level
  • VSTM $4.18
  • BLFY $9.81
  • Resistance Level
  • VSTM $4.85
  • BLFY $10.66
  • Average True Range (ATR)
  • VSTM 0.42
  • BLFY 0.29
  • MACD
  • VSTM -0.14
  • BLFY -0.13
  • Stochastic Oscillator
  • VSTM 10.70
  • BLFY 8.34

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

Share on Social Networks: